Trips, CBD and Traditional Medicines: Concepts and Questions
(2001; 88 pages)

Table des matières

ACKNOWLEDGEMENTS
LIST OF ABBREVIATIONS AND ACRONYMS
LIST OF RESOURCE PERSONS
EXECUTIVE SUMMARY
I. INTRODUCTION
II. CONTEXT
	2.1 Traditional medicine - brief overview
	2.2 Traditional medicine in Indonesia
	2.3 Bioprospecting
	2.4 About piracy and conservation
III. KEY INTERNATIONAL AGREEMENTS
	3.1 The Convention on Biological Diversity
	3.2 The TRIPS Agreement
	3.3 CBD versus TRIPS
IV. IPR & TRADITIONAL MEDICINE: MISMATCH
	4.1 Problems and limitations
	4.2 Diverging opinions
V. CONCEPTS, OBJECTIVES AND CONFLICTS
	5.1 Concepts on ownership of knowledge
	5.2 Objectives and conflicts
VI. OPTIONS AND CHOICES
	6.1 Traditional knowledge, customary law and incentives
	6.2 Options for protection
		6.2.1 Modifications of existing law
		6.2.2 Design 'sui generis' law
		6.2.3 The limits of law
		6.2.4 Other actions
	6.3 The choice to disclose
	6.4 Questions and dilemmas
VII. POLICIES AND STRATEGIES
	7.1 Balancing...
	7.2 A way forward?
VIII. EXAMPLES
	8.1 Costa Rica's Biodiversity Law and Bioprospecting Agreements
		8.1.1 The law
		8.1.2 Difficulties and challenges
		8.1.3 Bioprospecting agreements
	8.2 Legal Protection of Traditional Medicine and Knowledge in Thailand
	8.3 Philippines: Acts on Indigenous Peoples' Rights & Traditional Medicine
	8.4 The OAU's Model Law on Community Rights and Access to Biological Resources
	8.5 The Community Protocol and the draft ASEAN Framework Agreement on Access to Biological and Genetic Resources
WORKSHOP RECOMMENDATIONS
ANNEX A - Workshop Agenda
ANNEX B - Opening Remarks
ANNEX C - Selected Articles of the Convention on Biological Diversity
ANNEX D - List of Participants

Trips, CBD and Traditional Medicines: Concepts and Questions

Report of an ASEAN Workshop
on the TRIPS Agreement and
Traditional Medicine

Jakarta, 13-15 February 2001

Prepared by:
Karin Timmermans


National Agency for Drug and Food Control	World Health Organization

INDONESIA